JM 216
Term · Oncology and biomedicine · MLC-T-ONC-004586
A substance being studied in the treatment of prostate and other types of cancer. It contains the metal platinum and may kill cancer cells by damaging their DNA and stopping them from dividing. It is a type of alkylating agent. Also called BMS-182751 and satraplatin.
| Identifier | MLC-T-ONC-004586 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | BMS-182751; satraplatin |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-004586",
"term": "JM 216",
"field": "Oncology and biomedicine",
"definition": "A substance being studied in the treatment of prostate and other types of cancer. It contains the metal platinum and may kill cancer cells by damaging their DNA and stopping them from dividing. It is a type of alkylating agent. Also called BMS-182751 and satraplatin.",
"synonyms": [
"BMS-182751",
"satraplatin"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/jm-216/"
}
Record 9,699 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.